Use of inhibitors of the renin-angiotensin system
US7998953B2 · kind B2 · utility
0Cited by
23References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2005 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Dec 16, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08G61/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.